MedPath

The comparison of effect of levetiracetam and sodium valproate on seizure attacks frequency of 8-30 year old patients with juvenile myoclonic epilepsy

Phase 2
Conditions
Generalized idiopathic epilepsy.
Generalized idiopathic epilepsy and epileptic syndromes
Registration Number
IRCT2013112715567N1
Lead Sponsor
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
62
Inclusion Criteria

Patients with juvenile myoclonic epilepsy; Age between 8 and 30; Absence of brain lesion in MRI; Normal neurologic physical examination.
Exclusion criteria: Pregnancy; Secondary epilepsy; Levetiracetam, Lamotrigine or Sodium valproate receiving during last month; Severe organic disease; History of poor compliance.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of seizures. Timepoint: monthly. Method of measurement: according to history.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath